← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 2,161

Funds Holding Change +11

Funds Holding Growth +0.5%

Value $381B

Holding in Top 10 466

Top 10 Change -32

Top 10 Growth -6%

Value Growth +4%

New 99

Increased 883

Reduced 1,009

Closed 67

Capital Inflow $14.3B

Capital Outflow $22.2B

Net Capital Flow -$7.91B

Capital Flow Change -$388B

Calls $5.19B

Puts $5.36B

Net Calls -$171M

Put/Call Ratio 1.03